John Harrelson

437 total citations
16 papers, 304 citations indexed

About

John Harrelson is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, John Harrelson has authored 16 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in John Harrelson's work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (5 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). John Harrelson is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (5 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). John Harrelson collaborates with scholars based in United States. John Harrelson's co-authors include Michael W. Lee, Sidney D. Nelson, Steven Wrighton, Michael A. Mohutsky, Jialin Mao, Stephen D. Hall, William M. Atkins, Kirk R. Henne, Darwin O. V. Alonso and Brendan D. Stamper and has published in prestigious journals such as Biochemistry, Cancer and The FASEB Journal.

In The Last Decade

John Harrelson

16 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Harrelson United States 11 130 119 84 43 33 16 304
Sue Zhou United States 9 197 1.5× 117 1.0× 98 1.2× 41 1.0× 15 0.5× 9 345
Brith Leidvik Sweden 7 206 1.6× 146 1.2× 110 1.3× 30 0.7× 35 1.1× 8 347
Kelly Regal United States 9 119 0.9× 150 1.3× 73 0.9× 37 0.9× 26 0.8× 12 310
C. Lu United States 7 114 0.9× 92 0.8× 101 1.2× 22 0.5× 19 0.6× 10 284
Stephan Riedmaier Germany 8 129 1.0× 106 0.9× 94 1.1× 33 0.8× 26 0.8× 8 322
Irina Grabovec Belarus 8 169 1.3× 200 1.7× 55 0.7× 36 0.8× 22 0.7× 17 409
Carlo Sensenhauser United States 11 140 1.1× 126 1.1× 73 0.9× 41 1.0× 25 0.8× 12 352
Martin Perreault Canada 12 70 0.5× 111 0.9× 90 1.1× 23 0.5× 25 0.8× 21 374
B. Kevin Park United Kingdom 10 160 1.2× 95 0.8× 91 1.1× 51 1.2× 10 0.3× 15 416
Caitlin Lynch United States 14 171 1.3× 154 1.3× 91 1.1× 94 2.2× 34 1.0× 26 464

Countries citing papers authored by John Harrelson

Since Specialization
Citations

This map shows the geographic impact of John Harrelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Harrelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Harrelson more than expected).

Fields of papers citing papers by John Harrelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Harrelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Harrelson. The network helps show where John Harrelson may publish in the future.

Co-authorship network of co-authors of John Harrelson

This figure shows the co-authorship network connecting the top 25 collaborators of John Harrelson. A scholar is included among the top collaborators of John Harrelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Harrelson. John Harrelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Espiritu, Michael J., Justin Chen, Michael J. Larkin, et al.. (2020). Mechanisms of Herb-Drug Interactions Involving Cinnamon and CYP2A6: Focus on Time-Dependent Inhibition by Cinnamaldehyde and 2-Methoxycinnamaldehyde. Drug Metabolism and Disposition. 48(10). 1028–1043. 11 indexed citations
2.
Harrelson, John, et al.. (2020). Time‐dependent Inhibition of Cytochrome P450 2A13 (CYP2A13): by Cinnamaldehyde as a Lung Cancer Preventive Agent. The FASEB Journal. 34(S1). 1–1. 2 indexed citations
3.
Harrelson, John, et al.. (2019). Critical functions of the polyamine putrescine for proliferation and viability of Leishmania donovani parasites. Amino Acids. 52(2). 261–274. 10 indexed citations
4.
Harrelson, John, et al.. (2019). Structure‐Toxicity Relationships of Trans‐Cinnamic Aldehyde and Its Substituted Analogs. The FASEB Journal. 33(S1). 1 indexed citations
5.
Harrelson, John, et al.. (2018). Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer. European Journal of Pharmacology. 835. 61–74. 71 indexed citations
6.
Stamper, Brendan D., Amber V. Buhler, John Harrelson, et al.. (2017). Forecasting academic success through implementation of an online prerequisite review tutorials program for first year pharmacy students. Currents in Pharmacy Teaching and Learning. 9(2). 261–271. 4 indexed citations
7.
Harrelson, John & Michael W. Lee. (2016). Expanding the view of breast cancer metabolism: Promising molecular targets and therapeutic opportunities. Pharmacology & Therapeutics. 167. 60–73. 38 indexed citations
8.
Oshiro, Takashi, Sean C. Thomas, Akira Higa, et al.. (2016). Inactivation of CYP2A6 by the Dietary Phenylpropanoid trans-Cinnamic Aldehyde (Cinnamaldehyde) and Estimation of Interactions with Nicotine and Letrozole. Drug Metabolism and Disposition. 44(4). 534–543. 16 indexed citations
9.
Roberts, Sigrid C., et al.. (2016). The Polyamine Pathway of Leishmania donovani as a Potential Therapeutic Target. The FASEB Journal. 30(S1). 2 indexed citations
10.
Harrelson, John, et al.. (2014). Allosteric Modulation of Substrate Motion in Cytochrome P450 3A4-Mediated Xylene Oxidation. Biochemistry. 53(6). 1018–1028. 2 indexed citations
11.
Mao, Jialin, Michael A. Mohutsky, John Harrelson, Steven Wrighton, & Stephen D. Hall. (2012). Predictions of Cytochrome P450-Mediated Drug-Drug Interactions Using Cryopreserved Human Hepatocytes: Comparison of Plasma and Protein-Free Media Incubation Conditions. Drug Metabolism and Disposition. 40(4). 706–716. 30 indexed citations
12.
Harrelson, John, Brendan D. Stamper, J. D. Chapman, David R. Goodlett, & Sidney D. Nelson. (2012). Covalent Modification and Time-Dependent Inhibition of Human CYP2E1 by the meta-Isomer of Acetaminophen. Drug Metabolism and Disposition. 40(8). 1460–1465. 11 indexed citations
13.
Mao, Jialin, Michael A. Mohutsky, John Harrelson, Steven Wrighton, & Stephen D. Hall. (2011). Prediction of CYP3A-Mediated Drug-Drug Interactions Using Human Hepatocytes Suspended in Human Plasma. Drug Metabolism and Disposition. 39(4). 591–602. 45 indexed citations
14.
Harrelson, John, William M. Atkins, & Sidney D. Nelson. (2008). Multiple-Ligand Binding in CYP2A6: Probing Mechanisms of Cytochrome P450 Cooperativity by Assessing Substrate Dynamics. Biochemistry. 47(9). 2978–2988. 34 indexed citations
15.
Harrelson, John, Kirk R. Henne, Darwin O. V. Alonso, & Sidney D. Nelson. (2006). A comparison of substrate dynamics in human CYP2E1 and CYP2A6. Biochemical and Biophysical Research Communications. 352(4). 843–849. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026